ABSTRACT We studied the effect of nitroglycerin-induced decreases in mean arterial pressure (MAP) on myocardial salvage. Two hours after occlusion of the left anterior descending coronary artery, 65 conscious dogs were randomly allocated to receive 4 hr intravenous infusions of saline (group 1, 19 dogs), or nitroglycerin in doses to decrease MAP by 10% (group 2, 18 dogs), 25% (group 3, 14 dogs), and 50% (group 4, 14 dogs), respectively. At 7 days, 41 dogs were killed for measurement of infarct size; 24 dogs, given 7 to 10 gm radioactive microspheres for flow calculations, were killed 6 hr after occlusion. Boundaries of the occluded bed were defined by postmortem coronary arteriography. descending artery (LAD) was occluded in conscious dogs, nitroglycerin increased collateral blood flow but did not reduce infarct size when MAP was dropped by 16% (from 103 to 84 mm Hg).'4 It is well recognized that coronary perfusion pressure is a major factor in determining collateral blood flow'5 and limiting infarct size.'6 Since nitroglycerin dilates systemic and coronary vessels, it is possible that the dilated coronary bed in ischemic regions becomes critically dependent on coronary perfusion pressure during nitroglycerin infusion. This study was performed to determine the effects of three levels of nitroglycerin-induced hypotension on myocardial salvage and collateral blood flow.
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Methods
One hundred and eight mongrel dogs that weighed 14 to 24 kg JUGDUTT first diagonal branch. Plastic catheters were placed in the external jugular vein, internal carotid artery, and left atrium. The distal ends of the catheters and snare were tunneled subcutaneously and exteriorized behind the neck. After surgery, penicillin (1 million units) and streptomycin (1 g) were given intramuscularly, and the catheters were filled with heparinized saline. Experiments were done 7 to 10 days later on 97 healthy surviving dogs. On the morning of the study, the dogs were made to stand in a sling for support. Left atrial and aortic pressures (Statham P23Db), and lead II of the electrocardiogram (ECG) were recorded continuously on a pen recorder (Gould). After 30 min of baseline recordings, the snare was pulled to permanently occlude the LAD and a clamp was applied on the plastic tube. The dogs received morphine (0.3 to 0.5 mg/kg iv) 5 min after occlusion for analgesia and mild sedation, and lidocaine (1 mg/kg iv) to suppress ventricular arrhythmias. We randomly allocated 89 surviving dogs to four treatment groups 2 hr after occlusion. Control animals (group 1, 28 dogs) were given an intravenous infusion of 200 ml of 0.9% saline over 4 hr. In the three other groups, nitroglycerin infusions were titrated to reduce MAP as follows: by 10% but not below 80 mm Hg in group 2 (20 dogs), by 25% but not below 70 mm Hg in group 3 (19 dogs) , and by 50% but not below 50 mm Hg in group 4 (22 dogs) . No further morphine, lidocaine, or other drugs were given during the infusions. Twelve dogs died of ventricular fibrillation during the treatments (five in group 1, one in group 2, two in group 3, and four in group 4). We prepared the nitroglycerin solutions immediately before each infusion by dissolving 0.6 mg sublingual tablets in 0.9% saline in a final concentration of 1.2 mg/ml. The nitroglycerin infusions were carefully monitored and adjusted to maintain MAP at the desired levels, with average infusion rates (,ug/kg/min) of 10.6 (range, 2.5 to 16.0) in group 2, 31.9 (range, 1.7 to 52.5) in group 3, and 48.5 (range, 14.6 to 65.0) in group 4. Corresponding infusion rates (gg/min) were 211, 637, and 970, respectively, in the three groups. The corresponding volumes of nitroglycerin solutions averaged 42, 127, and 194 ml, respectively, in the three groups.
Serial measurements of regional myocardial blood flow (RMBF) were successfully made in 24 dogs (six dogs in each of the four groups) with injections of radioactive microspheres,17 7 to 10 ,um in diameter, with Tween-80 added and labeled with one of three different isotopes: 141Ce, 85Sr, or 46Sc (NEN Co.).
The microspheres were sonicated for 5 min before each injection, which consisted of 4 x 106 microspheres into the left atrium followed by 5 ml saline over 10 sec. Arterial blood samples were withdrawn for reference purposes at a constant rate of 2.06 ml/min on a calibrated Harvard pump, over 3 min and starting 30 sec before each microsphere injection. Determinations of RMBF were made (1) 10 min before occlusion, (2) 2 hr after occlusion just before the infusions were started, and (3) 6 hr after occlusion just before the infusions were stopped. To avoid the possibility of underestimation of RMBF due to microsphere loss from necrotic regions,'8 these 24 dogs were killed after the flow measurements taken 6 hr after occlusion. Of the remaining 53 dogs, 12 died over the next 6 days (four from group 1, one from group 2, three from group 3, and four from group 4), and 41 dogs were killed at 7 days for measurement of infarct size. All dogs were killed with a lethal dose of anesthetic. The hearts were then removed, washed free of blood, and weighed.
Measurement of occluded bed size and infarct size. Postmortem coronary arteriography was performed on all fresh hearts to define anatomic boundaries of the occluded bed. 9 Simultaneous injections of a barium sulfate-gelatin mass were made under a controlled pressure of 160 mm Hg via cannulas placed at the origins of the right, left circumflex, and LAD coronary arteries. The volume of these injections averaged 4 This error would have altered the mass of the occluded bed in the average heart in this study by 1.9 g. On reexamination of the initial markings by the same two observers, boundaries had to be shifted by 1 to 5 mm in 34 instances (34/650 or 5%) from 13 hearts, mainly in the septal region of the first two sections.
The left ventricular transverse sections were weighed after removal of the right ventricle, fatty and valvular tissue, and large epicardial vessels. We traced outlines of each left ventricular ring and infarcts (determined by gross inspection) on plastic overlays, without knowledge of treatments. By superimposition of these tracings on the marked radiographs through the use of metallic markers and natural markers (cavity contour, papillary muscles, septum, and junctions with the right ventricle) for alignment, markings of the occluded bed were copied. Areas of the infarcts, occluded beds, and left ventricular rings were then measured by planimetry (HP digitizer 9874A). Infarct and occluded bed mass were computed for each ring by relation of its average area (top and bottom surfaces) to its weight. 19 We then computed the total mass of infarct and occluded bed for each heart by summing values for individual rings. Interobserver error in contouring infarct outlines in the 36 hearts was negligible, since the areas of infarcts differed by 1.8 + 0.9% (n = 144 observations). Myocardial salvage was defined as the amount of uninfarcted myocardium in the occluded bed and expressed as percent of the occluded bed ( figure 1) .
Maps of the infarct within the occluded bed in each left ventricular ring were plotted from linear and angular measurements (figure 1) made with the digitized data and a computer program (HP 9835A). The data for corresponding left ventricular rings of all hearts with infarcts within each group were used to reconstruct average maps with the same computer program.
Measurement of RMBF. The markings of the occluded bed were transferred to the left ventricular rings to facilitate tissue sampling in the 24 hearts (without visible infarcts) from dogs killed 6 hr after occlusion. From the rings below the occlusion, bed. Border region samples in the occluded bed were taken at least 10 mm from the marked boundaries. All samples were divided into inner and outer halves, which were weighed, placed in vials containing 10% Formalin, and counted for radioactivity together with the reference blood samples in a well-type gamma scintillation counter (Tracor Northern 2250) at three energy windows adjusted to the peak emission of the nuclides. RMBF (ml/minlg) was calculated from the formula: RMBF = Cm x R/Cr, where Cm = corrected counts per gram in myocardial samples, R = withdrawal rate of arterial blood (ml/ min), and Cr = counts in the reference blood sample. We calculated flows for the four main regions of each heart by pooling samples from corresponding regions of the left ventricular rings. Coronary vascular resistance (mm Hg/ml/min/g) in each region was calculated by dividing the MAP by flow. 20 Histology. Samples were taken from the central regions within the occluded beds in the 41 hearts removed at 7 days. Histologic sections were made in the same planes as the surfaces measured by planimetry and were stained with hematoxylin and eosin; total necrosis was assessed by microscopic examination. The percent of visual necrosis as measured by planimetry was in agreement with the percent of histologic necrosis (visual -0.97 histologic + 5.89; r = .95, n = 30, p < .001).
Statistics. Raw data at different steps of collection were coded for analysis at the end of the study. The following statistical methods were used: (1) analyses of variance (ANOVA) to calculate the significance of differences within and among groups; (2) linear regression analysis by the least square fit method, and the significance of r values and slopes by ANOVA; (3) the 2 by 4 x2 test (with ANOVA) to assess the significance of differences in event frequency among groups; (4) ANOVA for the two flows measured after occlusion in the four main regions within groups; and (5) repeated measures ANOVA for hemodynamic changes. Results are given as mean + SD, with p values.
Results
Mortality and morbidity of experimental animals. Of the 97 dogs that underwent LAD occlusion, 20 died (21 %) of ventricular fibrillation within 6 hr (eight by 2 hr and another 12 by 6 hr). Twelve more dogs died between 1 and 6 days after occlusion (four in group l, one in group 2, three in group 3, and four in group 4). By exclusion of 24 dogs that were killed 6 hr after occlusion, the total mortality by 7 days was 32 of 73, or 44%. Mortality between 2 hr and 7 days after occlusion was not significantly different among the four groups (group 1, nine of 22; group 2, two of 14; group 3, three of 13; group 4, eight of 16; X2 = 4.06,p> .1). Complete coronary occlusion was confirmed at autopsy and postmortem coronary arteriography in all dogs. Among the 12 late deaths, autopsy revealed pulmonary congestion and large infarcts (25% to 35% of the left ventricle in seven dogs. Although the sizes of the occluded beds among the dogs that suffered sudden death were within the range of values for the four groups (8.8% to 64.8% of the left ventricle), the average sizes for the 32 dogs dying between 2 hr and 7 days after occlusion exceeded that for the 41 survivors (41.9 ± 12.3 vs 34.4 + 12.7; p < .025).
Hemodynamics. The hemodynamic changes for the four treatment groups are summarized in table 1. Heart rate before occlusion, MAP, and mean left atrial pressure were similar. After coronary occlusion, heart rate and mean left atrial pressure increased significantly (p < .001), but MAP did not change. These changes were maintained over the next 2 hr in all dogs and during the subsequent 4 hr in the control animals. In the nitroglycerin-treated groups, the desired decreases (p < .001) in MAP were produced and maintained throughout the 4 Electrocardiograms. In all dogs, ECGs taken after occlusion showed ST segment elevation in leads I, aVL, and V4. For the 41 dogs surviving 7 days, the incidence of significant Q waves (>0.03 sec and 0.2 mV) were similar (NS) among the four groups (10/13 vs 7/12 vs 7/8 vs 8/8, respectively). In these dogs, the average Lown score of arrhythmias were also similar among the four groups (I.3 + 1.0 vs 0.9 + 0.9 vs 1.3 ± 1.4 vs 1.7 ± 1.2, respectively).
Infarct size. Infarct size data in the 41 dogs (13 in group 1, 12 in group 2, eight in group 3, and eight in CIRCULATION unchanged between 2 and 6 hr in group 1. Despite a downward trend in these ratios in LAD center and margin regions of groups 2 and 3 and an upward trend in group 4 during the nitroglycerin infusions, none of these differences was statistically significant.
The calculated changes in regional coronary vascular resistance20 paralleled those in RMBF in all four groups. After occlusion, resistances increased throughout the occluded bed in all hearts, with gradi- contrast, resistances decreased throughout the occluded LAD bed in all the nitroglycerin-treated dogs, with transmural resistances between 2 and 6 hr after occlusion of 1245 ± 1443 vs 437 + 241 (p < .025) in the LAD center, 637 ± 480 vs 264 ± 106 (p < .025) in the LAD margin, and 244 ± 83 vs 151 ± 34 (p < .001) in the LAD border regions. Similar significant differences in resistances were found in inner and outer regions of the occluded bed during the nitroglycerin infusions among groups 2, 3, and 4. In the center of the nonoccluded left circumflex artery bed, the transmural resistance did not change with saline (107 ± 18 vs 103 ± 21, NS) or with nitroglycerin in group 2 (100 ± 13 vs 97 ± 12, NS), but decreased significantly with nitroglycerin (p < .005) in group 3 (111 ± 11 vs 75 ± 15) andgroup4 (111 ± 7 vs 79 ± 11).
Discussion
There were four important findings in this study. First, when given between 2 and 6 hr after LAD occlusion in conscious dogs, intravenous nitroglycerin reduced infarct size when there was a mild (10%) decrease Fourth, marked nitroglycerin-induced hypotension eliminated the beneficial effects of nitroglycerin on collateral blood flow. Thus, a highly significant increase in collateral blood flow occurred with mild hypotension in group 2, a small but statistically nonsignificant increase was detected with moderate hypotension in group 3, but there was no increase in collateral blood flow with marked hypotension in group 4, and flow to the center of the nonoccluded bed actually decreased. In contrast, computed coronary vascular resistance decreased significantly within the occluded 682 bed in all nitroglycerin-treated dogs. Furthermore, coronary resistance in the nonoccluded bed also decreased in groups 3 and 4, which received higher doses. Despite limitations of the method for calculating resistance,20 these findings support the concept that after nitroglycerin-induced coronary vasodilatation, collateral blood flow to ischemic regions is critically dependent on perfusion pressure.
In early animal studies of the effect of intravenous nitroglycerin on ischemic injury, bolus injections and fixed dose infusion rates (200 to 400 ,ug/min) were used, and methoxamine, an a-adrenergic agonist, was given to counteract the nitroglycerin-induced hypotension and associated reflex tachycardia.1' Such a dose of nitroglycerin in conscious dogs was found to decrease MAP by 20%, increase heart rate by 25%, and increase collateral blood flow.4 Also in the conscious dog, the minimum dose of intravenous nitroglycerin to exhibit a cardiovascular effect was 160 ug/min.23 In a previous study designed to test the hypothesis that nitroglycerin-increases in collateral blood flow might produce myocardial salvage in a 2 day conscious dog infarction model,19 the dose was titrated to produce a detectable decrease in MAP. ' 4 20, 2&28 and infarction'3 29 has been demonstrated previously, the relationship between this effect and nitroglycerin-induced hypotension has not been studied. In this study, nitroglycerin increased collateral blood flow between 2 and 6 hr after occlusion with modest decreases in blood pressure. This increase in flow might have been due to dilatation of collaterals or vessels from which they arise. Low doses of nitroglycerin have been suggested to markedly decrease tone in large conduit vessels,30 and this might have been the prevalent mechanism in group 2. Other possible explanations include nitroglycerin-mediated release of some other vasoactive compound such as prostaglandin E31 or prostaglandin 12,32 relief of coronary spasm, and a direct action on collaterals. Since small intrinsic coronary collaterals contain a layer of smooth muscle33 and may not be maximally vasodilated during myocardial ischemia,34 these vessels might have the potential for further vasodilation by nitroglycerin. Although the decrease in left ventricular filling pressure and subendocardial compressive forces in deep muscle in diastole might have been operative, this effect does not explain the lack of increase in collateral blood flow with greater decreases in MAP, since left ventricular filling pressure was similarly reduced in all nitroglycerin groups. Larger doses of nitroglycerin are known to decrease arteriolar resistance.30 When arterioles are fully dilated, changes in large vessel resistance cause changes in collateral blood flow and compromise the ability for autoregulation.30 This might explain both the lack of increase in collateral blood flow and the decrease in flow to normal regions with marked nitroglycerin-induced hypotension at higher doses in groups 3 and 4. Thus, the possible benefit of reduced afterload and associated decrease in myocardial oxygen demand was offset by decreased perfusion pressure. Coronary steal could not have been significant, since flow actually decreased in the normal region with marked nitroglycerin-induced hypotension. Moreover, a relative degree of coronary steal with high doses of nitroglycerin cannot be excluded, since flow to the normal zone decreased by only 14% and the rate-pressure product decreased by about 40%.
In this study, since flow was not measured after nitroglycerin was stopped, it is uncertain whether the increase was sustained beyond the 4 hr infusion period in group 2. In view of the myocardial salvage seen in dogs from this group killed at 7 days, it is likely that there was a persistent increase in collateral blood flow. Capurro et al. 4 showed that the combination of nitroglycerin and methoxamine, given between 10 and 70 min after coronary occlusion to closed-chest sedated dogs, caused a sustained increase in collateral blood flow that lasted for at least 5 hr. It is therefore possible that collaterals opened by nitroglycerin may remain open after nitroglycerin is stopped.
In conclusion, the results suggest that there is a narrow margin of safety for the beneficial effect of early nitroglycerin therapy during acute myocardial infarction. 
